Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 12:46 PM
Ignite Modification Date:
2025-12-25 @ 12:14 PM
NCT ID:
NCT02614261
Pre Assignment Details:
1. Main study: This randomised part of study was conducted in 3 phases
* a 3-month double-blind treatment phase
* an optional 9-month open-label extension phase
* a 4-month follow-up phase
2. Israel addendum: Participants in Israel who completed all phases in main study, benefited from galcanezumab and had no other suitable alternative treatment options available were provided continued-access to galcanezumab where safety was monitored.
Study:
NCT02614261
Study Brief:
Results Section:
NCT02614261